Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): A multicentre, double-blind, randomised, phase 2b dose-selection study
Background Clinical eff ectiveness of previous regimens to treat Plasmodium vivax infection have been hampered by compliance. We aimed to assess the dose-response, safety, and tolerability of single-dose tafenoquine plus 3-day chloroquine for P vivax malaria radical cure. Methods In this double-blin...
Saved in:
Main Authors: | Alejandro Llanos-Cuentas, Marcus V. Lacerda, Ronnatrai Rueangweerayut, Srivicha Krudsood, Sandeep K. Gupta, Sanjay K. Kochar, Preetam Arthur, Nuttagarn Chuenchom, Jörg J. Möhrle, Stephan Duparc, Cletus Ugwuegbulam, Jörg Peter Kleim, Nick Carter, Justin A. Green, Lynda Kellam |
---|---|
Other Authors: | Universidad Peruana Cayetano Heredia |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34830 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Performance of binaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects
by: Lyda Osorio, et al.
Published: (2018) -
Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria
by: Marcus V.G. Lacerda, et al.
Published: (2020) -
Tafenoquine treatment of Plasmodium vivax malaria: Suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
by: Pamela L. St Jean, et al.
Published: (2018) -
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
by: Pamela L. St Jean, et al.
Published: (2020) -
In-vitro interaction of tafenoquine and chloroquine in Plasmodium falciparum from northwestern Thailand
by: Anke Vollnberg, et al.
Published: (2018)